Get the Stockscreener App
181.70
2.31%
4.10
After Hours:
181.70
Overview
News
Price History
Option Chain
Financials
Why MASI Down?
Discussions
Forecast
Dividend History
Masimo Corp stock is traded at $181.70, with a volume of 430.12K.
It is up +2.31% in the last 24 hours and up +7.78% over the past month.
Masimo Corp is a global technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.
See More
Previous Close:
$177.60
Open:
$179.19
24h Volume:
430.12K
Relative Volume:
0.84
Market Cap:
$9.66B
Revenue:
$2.04B
Net Income/Loss:
$78.60M
P/E Ratio:
125.31
EPS:
1.45
Net Cash Flow:
$149.60M
1W Performance:
+8.10%
1M Performance:
+7.78%
6M Performance:
+70.71%
1Y Performance:
+40.91%
1-Day Range:
$179.19
$183.14
1-Week Range:
$168.00
$183.14
52-Week Range:
$101.61
$183.14
Masimo Corp Stock (MASI) Company Profile
Name
Masimo Corp
Sector
Industry
Phone
949-297-7000
Address
52 DISCOVERY, IRVINE, CA
Compare MASI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MASI
Masimo Corp
|
181.70 | 9.66B | 2.04B | 78.60M | 149.60M | 1.45 |
|
ABT
Abbott Laboratories
|
128.81 | 223.42B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
103.04 | 151.86B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
390.43 | 148.84B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
91.99 | 117.96B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
73.22 | 43.19B | 6.60B | 4.16B | 490.10M | 6.93 |
Masimo Corp Stock (MASI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-27-24 | Reiterated | Raymond James | Outperform |
| Nov-06-24 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jun-03-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-15-24 | Upgrade | Stifel | Hold → Buy |
| Mar-25-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-30-24 | Downgrade | Jefferies | Buy → Hold |
| Jan-03-24 | Downgrade | Needham | Buy → Hold |
| Nov-08-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jul-18-23 | Downgrade | Stifel | Buy → Hold |
| Jul-10-23 | Initiated | Wells Fargo | Equal Weight |
| Feb-22-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-15-22 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-05-22 | Reiterated | Needham | Buy |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Sep-15-22 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Sep-14-22 | Initiated | Loop Capital | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Feb-18-22 | Upgrade | Needham | Hold → Buy |
| Feb-16-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Oct-12-21 | Resumed | Raymond James | Mkt Perform |
| Sep-02-20 | Initiated | Robert W. Baird | Outperform |
| Aug-14-20 | Resumed | Piper Sandler | Overweight |
| Apr-20-20 | Downgrade | Needham | Buy → Hold |
| Mar-02-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-07-19 | Reiterated | Needham | Buy |
| Apr-16-19 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-13-19 | Reiterated | Needham | Buy |
| Dec-19-18 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Sep-14-18 | Initiated | Needham | Buy |
| Mar-09-18 | Initiated | Barclays | Overweight |
| Aug-14-17 | Upgrade | BTIG Research | Neutral → Buy |
| Apr-04-17 | Reiterated | Wedbush | Outperform |
| Mar-16-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Feb-27-17 | Reiterated | Wedbush | Outperform |
| Feb-13-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-04-16 | Reiterated | Wedbush | Outperform |
| May-05-16 | Upgrade | Piper Jaffray | Neutral → Overweight |
| May-05-16 | Reiterated | Wedbush | Outperform |
| Jan-06-16 | Downgrade | Raymond James | Strong Buy → Outperform |
| Aug-05-15 | Reiterated | ROTH Capital | Buy |
View All
Masimo Corp Stock (MASI) Latest News
Masimo stock soars to 52-week high, hits $181.13 By Investing.com - Investing.com South Africa
Can Masimo (MASI) Keep the Earnings Surprise Streak Alive? - Yahoo Finance
Apple defends against Masimo's trade secret claims after sealed trial - Daily Journal
Edwards Lifesciences Veteran Katie Szyman Named Next Masimo CEO - Orange County Business Journal
Crossmark Global Holdings Inc. Sells 88 Shares of Masimo Co. (NASDAQ:MASI) - Defense World
UMB Bank n.a. Purchases 123 Shares of Masimo Co. (NASDAQ:MASI) - Defense World
Midday Stock Roundup: Virgin Galactic down 2.3% and 87% YoY - Orange County Business Journal
Masimo names med-tech vet Katie Szyman CEO - BioWorld Online
Masimo taps Becton Dickinson executive Katie Szyman as CEO - Reuters
Here's Why Masimo (MASI) is a Great Momentum Stock to Buy - Yahoo Finance
Needham & Company LLC Reaffirms Hold Rating for Masimo (NASDAQ:MASI) - MarketBeat
Masimo Appoints Catherine ‘Katie’ Syzman as CEO & Board Member - Strata-gee.com
Deep Dive Into Masimo Stock: Analyst Perspectives (7 Ratings) - Benzinga
Masimo names Becton Dickinson's Katie Szyman CEO -January 21, 2025 at 04:57 pm EST - Marketscreener.com
Masimo Appoints Katie Szyman as Permanent CEO - Orange County Business Journal
Masimo Corp. (MASI) names Katie Szyman as new CEO - StreetInsider.com
Masimo Stock Gains Following Solid Preliminary Q4 Revenues - Yahoo Finance
Needham maintains Hold on Masimo stock following revenue preannouncement - MSN
MASI (Masimo) 3-Year FCF Growth Rate : -62.60% (As of Sep. 2024) - GuruFocus.com
Masimo (NASDAQ:MASI) Earns “Hold” Rating from Needham & Company LLC - Defense World
Masimo (NASDAQ:MASI) Receives Hold Rating from Needham & Company LLC - MarketBeat
Hold rating maintained for Masimo shares as analyst raises EPS and sales growth outlook - MSN
Masimo stock holds as Needham maintains rating - MSN
Needham maintains Hold on Masimo stock following revenue preannouncement By Investing.com - Investing.com UK
Masimo Corp. (MASI) Announces Select Preliminary 2024 Financial Results and 2025 Guidance - StreetInsider.com
What Does Masimo Corporation's (NASDAQ:MASI) Share Price Indicate? - Yahoo Finance
Masimo and Apple File Post-Trial Briefs in Apple Watch IP Dispute - USA Herald
Masimo, Apple Fight Over Watch IP In Post-Bench Trial Briefs - Law360
Masimo (NASDAQ:MASI) Share Price Crosses Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat
Apple and Masimo Spar After Apple Watch Trade-Secrets Retrial - Bloomberg Law
SHAREHOLDER ALERT: Morris Kandinov Investigating MASI, EXTR, POWW, and EP; Shareholders are Encouraged to Contact the Firm - GlobeNewswire Inc.
$1000 Invested In Masimo 15 Years Ago Would Be Worth This Much Today - Benzinga
MASIMO INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Masimo CorporationMASI - Business Wire
Masimo Co. (NASDAQ:MASI) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Principal Financial Group Inc. Decreases Holdings in Masimo Co. (NASDAQ:MASI) - MarketBeat
Masimo shares retain Outperform rating as analyst highlights margin expansion opportunities - Investing.com India
Masimo (NASDAQ:MASI) Stock Price Expected to Rise, Raymond James Analyst Says - MarketBeat
What Analysts Are Saying About Masimo Stock - Benzinga
Masimo shares retain Outperform rating as analyst highlights margin expansion opportunities By Investing.com - Investing.com South Africa
MASIMO INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Masimo CorporationMASI - The Malaysian Reserve
The Zacks Analyst Blog Highlights Veracyte, Omnicell, Masimo and Abbott Laboratories - Yahoo Finance
Those who invested in Masimo (NASDAQ:MASI) a year ago are up 50% - Yahoo Finance
Kovitz Investment Group Partners LLC Invests $499,000 in Masimo Co. (NASDAQ:MASI) - MarketBeat
State Street Corp Boosts Position in Masimo Co. (NASDAQ:MASI) - MarketBeat
A Look Into Masimo Inc's Price Over Earnings - Benzinga
Apple, Masimo Push Court to Clarify Willful-Infringement Stance - Bloomberg Law
Expert Ratings For Masimo - Benzinga
Masimo lays off 75 employees in California - MedTech Dive
SEC Investigates RTW Investments for Involvement in Masimo Proxy Fight - Orange County Business Journal
Masimo Corp Stock (MASI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
0.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):